14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial-Reference-Cited by-同舟云学术

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

Published:2012-09 Issue:9846 Volume:380 Page:986-993
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Diacon Andreas H,Dawson Rodney,von Groote-Bidlingmaier Florian,Symons Gregory,Venter Amour,Donald Peter R,van Niekerk Christo,Everitt Daniel,Winter Helen,Becker Piet,Mendel Carl M,Spigelman Melvin K

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Global tuberculosis control: WHO report,2011

2. Role of individual drugs in the chemotherapy of tuberculosis;Mitchison;Int J Tuberc Lung Dis,2000

3. Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis;Rustomjee;Antimicrob Agents Chemother,2008

4. Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients;Diacon;Antimicrob Agents Chemother,2010

5. A phase II dose-ranging trial of the early bactericidal activity of PA-824;Diacon;Antimicrob Agents Chemother,2012

Cited by 377 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-01-25

2. The quest to deliver high-dose rifampicin: can the inhaled approach help?;Expert Opinion on Drug Delivery;2024-01-02

3. Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention;MedComm;2024-01

4. Preparation and in vitro osteogenic evaluation of high-strength ceramic artificial bone loaded with anti-tuberculosis drug PaMZ;AIP Advances;2023-11-01

5. Model‐based dose optimization framework for bedaquiline, pretomanid and linezolid for the treatment of drug‐resistant tuberculosis;British Journal of Clinical Pharmacology;2023-10-26